Serotypes and clones causing invasive pneumococcal disease before the use of new conjugate vaccines in Catalonia, Spain

Journal of Infection

Volumn 63, Issue 2, 2011, Pages 151-162

  Muñoz Almagro, Carmen ^a   Ciruela, Pilar ^b   Esteva, Cristina ^a   Marco, Francesc ^c   Navarro, Marian ^d   Bartolome, Rosa ^e   Sauca, Goretti ^f   Gallés, Carmen ^g   Morta, Montse ^h   Ballester, Frederic ⁱ   Raga, Xavier ^j   Selva, Laura ^a  

^a HOSPITAL SANT JOAN DE DÉU   (Spain)

^b GENERALITAT DE CATALUNYA   (Spain)

^c INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^d HOSPITAL GENERAL DE VIC   (Spain)

^e HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^f HOSPITAL DE MATARÓ   (Spain)

^g Hospital Sant Jaume de Calella   (Spain)

^h Althaia   (Spain)

ⁱ HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^j Hospital Sant Pau i Santa Tecla   (Spain)

more..

Author keywords

Clones; Empyema; Pneumococcal vaccine; Pneumonia; Serotypes; Streptococcus pneumoniae

Indexed keywords

CEFOTAXIME; CHLORAMPHENICOL; ERYTHROMYCIN; LEVOFLOXACIN; PENICILLIN G; PNEUMOCOCCUS VACCINE; TETRACYCLINE;

ADOLESCENT; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHILD; CLINICAL EFFECTIVENESS; CLONAL SPECIES; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SURVEILLANCE; DRUG EFFICACY; EMPYEMA; FEMALE; GENETIC VARIABILITY; HUMAN; INFECTION PREVENTION; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; MASS IMMUNIZATION; MOLECULAR CLONING; MOLECULAR EPIDEMIOLOGY; PNEUMOCOCCAL INFECTION; PNEUMOCOCCAL MENINGITIS; PRESCHOOL CHILD; SEROTYPE; SPAIN; STREPTOCOCCUS PNEUMONIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MULTILOCUS SEQUENCE TYPING; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PREVALENCE; PROSPECTIVE STUDIES; SEROTYPING; SPAIN; STREPTOCOCCUS PNEUMONIAE; VACCINES, CONJUGATE; YOUNG ADULT;

EID: 79960892484     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2011.06.002     Document Type: Article

References (39)

1. O'Brien K.L., Wolfson L.J., Watt J.P., Henkle E., Deloria-Knoll M., McCall N., et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 2009, 374:893-902.
2. Raising the profile of pneumococcal disease April 2010, Preventpneumo, last accesed 14. http://www.preventpneumo.org/results/pneumoadip_activities/upload/Five-Yr-Media-Report-2003-to-2008-FINAL.pdfData.
3. Pilishvili T., Lexau C., Farley M.M., Hadler J., Harrison L.H., Bennett N.M., et al. Active bacterial core surveillance/emerging infections program network. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 2010, 201:32-41.
4. Lucero M.G., Dulalia V.E., Nillos L.T. Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and X-ray defined pneumonia in children less than two years of age. Cochrane Database Syst Rev 2009, 4:CD004977.
5. Pulido M., Sorvillo F. Declining invasive pneumococcal disease mortality in the United States, 1990-2005. Vaccine 2010, 28:889-892.
6. Hausdorff W.P., Bryant J., Paradiso P.R., Siber G.R. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis 2000, 30:100-121.
7. Vallès X., Flannery B., Roca A., Mandomando I., Sigaúque B., Sanz S., et al. Serotype distribution and antibiotic susceptibility of invasive and nasopharyngeal isolates of Streptococcus pneumoniae among children in rural Mozambique. Trop Med Int Health 2006, 11:358-366.
8. Grijalva C.G., Nuorti J.P., Arbogast P.G., Martin S.W., Edwards K.M., Griffin M.R. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet 2007, 369:1179-1186.
9. De Wals P., Robin E., Fortin E., Thibeault R., Ouakki M., Douville-Fradet M. Pneumonia after implementation of the pneumococcal conjugate vaccine program in the province of Quebec, Canada. Pediatr Infect Dis J 2008 Nov, 27(11):963-968.
10. Jardine A., Menzies R.I., McIntyre P.B. Reduction in hospitalizations for pneumonia associated with the introduction of a pneumococcal conjugate vaccination schedule without a booster dose in Australia. Pediatr Infect Dis J 2010 Jul, 29(7):607-612.
11. Li S.T., Tancredi D.J. Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine. Pediatrics 2010 Jan, 125(1):26-33. 30.
12. Eastham K.M., Freeman R., Kearns A.M., Eltringham G., Clark J., Leeming J., et al. Clinical features, aetiology and outcome of empyema in children in the north east of England. Thorax 2004, 59:522-525.
13. Byington C.L., Samore M., Stoddard G.J., Barlow S., Daly J., Korgenski K., et al. Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups. Clin Infect Dis 2005, 41:21-29.
14. Muñoz-Almagro C., Jordan I., Gene A., Latorre C., Garcia-Garcia J.J., Pallares R. Emergence of invasive pneumococcal disease caused by non-vaccine serotypes in the era of 7-valent conjugate vaccine. Clin Infect Dis 2008, 46:174-182.
15. Ardanuy C., Tubau F., Pallares R., Calatayud L., Domínguez M.A., Rolo D., et al. Epidemiology of invasive pneumococcal disease among adult patients in Barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction, 1997-2007. Clin Infect Dis 2009, 48:57-64.
16. Lin C.J., Chen P.Y., Huang F.L., Lee T., Chi C.S., Lin C.Y. Radiographic, clinical, and prognostic features of complicated and uncomplicated community-acquired lobar pneumonia in children. J Microbiol Immunol Infect 2006, 39:489-495.
17. Greenberg D., Givon-Lavi N., Newman N., Bar-Ziv J., Dagan R. Nasopharyngeal carriage of individual Streptococcus pneumoniae serotypes during pediatric pneumonia as a means to estimate serotype disease potential. Pediatr Infect Dis J 2011 Mar, 30(3):227-233.
18. Jefferies J.M., Smith A.J., Edwards G.F., McMenamin J., Mitchell T.J., Clarke S.C. Temporal analysis of invasive pneumococcal clones from Scotland illustrates fluctuations in diversity of serotype and genotype in the absence of pneumococcal conjugate vaccine. J Clin Microbiol 2010 Jan, 48(1):87-96.
19. Brueggemann A.B., Spratt B.G. Geographic distribution and clonal diversity of Streptococcus pneumoniae serotype 1 isolates. J Clin Microbiol 2003, 41:4966-4970.
20. Servei Catala de la Salut June 9, 2010, Informe del registre del conjunt minim Basic de dades (CMBD), Available at, last accessed. http://www10.gencat.cat/catsalut/cat/prov_cmbd.htmData.
21. Tarrago D., Fenoll A., Sanchez-Tatay D., Arroyo L.A., Muñoz-Almagro C., Esteva C., et al. Identification of pneumococcal serotypes from culture-negative clinical specimens by novel real-time PCR. Clin Microbiol Infect 2008, 14:828-834.
22. Performance standards for antimicrobial susceptibility testing. Eighteenth informational supplement. CLSI document M100-S18 2008, National Committee for Clinical Laboratory Standards (NCCLS), ISBN 1-5-56238-653-0, Clinical and Laboratory Standard Institute, Wayne PA.
23. Muñoz-Almagro C., Esteva C., de Sevilla M.F., Selva L., Gene A., Pallares R. Emergence of invasive pneumococcal disease caused by multidrug-resistant serotype 19A among children in Barcelona. J Infect 2009 Aug, 59(2):75-82.
24. Ardanuy C., Rolo D., Fenoll A., Tarrago D., Calatayud L., Liñares J. Emergence of a multidrug-resistant clone (ST320) among invasive serotype 19A pneumococci in Spain. J Antimicrob Chemother 2009 Sep, 64(3):507-510.
25. Enright M.C., Spratt B.G. A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 1998, 144:3049-3060.
26. Feil E.J., Li B.C., Aanensen D.M., Hanage W.P., Spratt B.G. eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J Bacteriol 2004, 186:1518-1530.
27. Choi E.H., Kim S.H., Eun B.W., Kim S.J., Kim N.H., Lee J., et al. Streptococcus pneumoniae serotype 19A in children, South Korea. Emerg Infect Dis 2008, 14:275-281.
28. Pillai D.R., Shahinas D., Buzina A., Pollock R.A., Lau R., Khairnar K., et al. Genome-wide dissection of globally emergent multi-drug resistant serotype 19A Streptococcus pneumoniae. BMC Genomics 2009, 10:642.
29. Aguiar S.I., Pinto F.R., Nunes S., Serrano I., Melo-Cristino J., Sá-Leão R., et al. Denmark 14-230 clone as an increasing cause of pneumococcal infection in Portugal within a background of diverse serotype 19A lineages. J Clin Microbiol 2010, 48:101-108.
30. Sener B., McGee L., Pinar A., Eser O. Genomic backgrounds of drug-resistant streptococcus pneumoniae in Ankara, Turkey: identification of emerging new clones. Microb Drug Resist 2006, 12:109-114.
31. Moore M.R., Gertz R.E., Woodbury R.L., Barkocy-Gallagher G.A., Schaffner W., Lexau C., et al. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J Infect Dis 2008, 197:1016-1027.
32. Tarragó D., Aguilar L., García R., Gimenez M.J., Granizo J.J., Fenoll A. Evolution of clonal and susceptibility profiles of serotype 19A Streptococcus pneumoniae among invasive isolates from children in Spain, 1990 to 2008. Antimicrob Agents Chemother 2011 May, 55(5):2297-2302.
33. Aguiar S.I., Brito M.J., Gonçalo-Marques J., Melo-Cristino J., Ramirez M. Serotypes 1, 7F and 19A became the leading causes of pediatric invasive pneumococcal infections in Portugal after 7 years of heptavalent conjugate vaccine use. Vaccine 2010, 28:5167-5173.
34. Picazo J., Ruiz-Contreras J., Casado-Flores J., Giangaspro E., Del Castillo F., Hernández-Sampelayo T., et al. Relationship between serotypes, age, and clinical presentation of invasive pneumococcal disease in Madrid, Spain, after introduction of the 7-valent pneumococcal conjugate vaccine into the vaccination calendar. Clin Vaccine Immunol Jan 2011, 18(1):89-94. Heracles Study Group.
35. Grall N., Hurmic O., Al Nakib M., Longo M., Poyart C., Ploy M.C., et al. ORP Ile de France Ouest. Epidemiology of Streptococcus pneumoniae in France before introduction of the PCV-13 vaccine. Eur J Clin Microbiol Infect Dis Apr 18 2011, [Epub ahead of print].
36. Gertz R.E., Li Z., Pimenta F.C., Jackson D., Juni B.A., Lynfield R., et al. Active bacterial core surveillance team. Increased penicillin nonsusceptibility of nonvaccine-serotype invasive pneumococci other than serotypes 19A and 6A in post-7-valent conjugate vaccine era. J Infect Dis 2010, 201:770-775.
37. Antimicrobial resistance Special eurobarometro 338, November-December 2009 Available from, last accessed 14 may 2011. http://ec.europa.eu/health/antimicrobial_resistance/docs/ebs_338_en.pdfData.
38. Birtles A., McCarthy N., Sheppard C.L., Rutter H., Guiver M., Haworth E., et al. Multilocus sequence typing directly on DNA from clinical samples and a cultured isolate to investigate linked fatal pneumococcal disease in residents of a shelter for homeless men. J Clin Microbiol 2005, 43:2004-2008.
39. Jefferies J.M., Johnston C.H., Kirkham L.A., Cowan G.J., Ross K.S., Smith A., et al. Presence of nonhemolytic pneumolysin in serotypes of streptococcus pneumoniae associated with disease outbreaks. J Infect Dis 2007, 196:936-944.